Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, May 30 2016 3:08am ET - U.S. Markets open in 6 hours and 22 minutes.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Delivery News
Latest News
Friday, May 27, 2016
·Valeant: Here Come the Buyers?
at Barrons.com - Fri May 27
·Valeant: Ackman's Not One to Cut and Run
at The Wall Street Journal Online - Fri May 27
·Intellipharmaceutics Announces Pricing of $5.2 Million Public Offering of Common Shares and Warrants
GlobeNewswire - Fri May 27
·Valeant (VRX) Stock Surges on Rejected Takeda, TPG Bid Speculation
at TheStreet.com - Fri May 27
·Valeant 'Received Bid Proposal' From Takeda, TPG
at TheStreet.com - Fri May 27
·[$$] Valeant shares rise on reports of rebuffed offer from Takeda
at FT.com - Thu May 26
·Valeant rejected takeover bid from Takeda, TPG: report
at MarketWatch - Thu May 26
·Wally Weitz Drops Falling Drug Stock Endo but Sees 'Upside Potential'
- Thu May 26
·Intellipharmaceutics Announces Proposed Public Offering of Units of Common Shares and Warrants
GlobeNewswire - Thu May 26
Thursday, May 26, 2016
·U.S. FDA approves first-ever implant to treat opioid addiction
Reuters - Thu May 26
·Valeant Hires Sam Eldessouky As SVP And Corporate Controller
- Thu May 26
·Valeant (VRX) Stock Up, Appoints Tyco's Eldessouky Corporate Controller
at TheStreet.com - Thu May 26
·Valeant names Tyco executive Sam Eldessouky as corporate controller
at MarketWatch - Thu May 26
·Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller
PR Newswire - Thu May 26
·Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller
CNW Group - Thu May 26
·Alkermes Appoints Nancy Snyderman, M.D., to Board of Directors
Business Wire - Thu May 26
·Valeant Filing: CEO to Earn $1.5M, More if He Meets Goals
at TheStreet.com - Wed May 25
·Valeant Ties New CEO's Pay to Incentives
at TheStreet.com - Wed May 25
Wednesday, May 25, 2016
·Pharming Reports on Annual General Meeting of Shareholders Pharming's Board of Supervisory Directors Announce Paul Sekhri as New Chairman
PR Newswire - Wed May 25
·Alkermes Initiates Phase 1 Clinical Trial Of Immuno-Oncology Drug Candidate ALKS 4230
- Wed May 25
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?